US Patent 11185537 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Patent 11185537 was granted and assigned to Novartis on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+74 characters)
Article
Patent abstract
The present disclosure provides a compound of Formula (I′):
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111855370
Date of Patent
November 30, 2021
0Patent Application Number
165043760
Date Filed
July 8, 2019
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111855370
Date of Patent
November 30, 2021
0Patent Application Number
165043760
Date Filed
July 8, 2019
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11185537 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11185537
Date of patent
November 30, 2021
Patent application number
16504376
Date Filed
July 8, 2019
Patent primary examiner
Find more entities like US Patent 11185537 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
